Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 3, 2026

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Sep 1, 2026

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Aug 20, 2026

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.

Zacks Investment Research • Aug 13, 2026

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Aug 12, 2026

Pediatrix Medical Tops Q2 Earnings on Better Cash Collections

MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.

Zacks Investment Research • Aug 6, 2026

Pediatrix Medical Group Q2 Earnings Call Highlights

Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and reaffirmed its full-year adjusted EBITDA outlook of $280 million to $300 million, as stronger revenue-cycle-management collections, payer mix and patient acuity offset lower patient-service volumes.

MarketBeat • Aug 5, 2026

Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript

Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 4, 2026

Pediatrix Medical Group Reports Second Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.

Business Wire • Aug 4, 2026

Pediatrix Medical Group (MD) Beats Q2 Earnings and Revenue Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.53 per share a year ago.

Zacks Investment Research • Aug 4, 2026